First, there is a lack of application of NSCs to large-scale clinical trials in AD [103] because isolation and enough expansion of NSCs from the central nervous system are difficult in vitro, and require culture medium supplemented with mitogenic growth factors, such as epidermal growth factor and basic fibroblast growth factor [104]. This evidence concerns the gene FGF2 and Alzheimer disease.